Literature DB >> 7018485

Lipid absorption and intestinal lipoprotein formation.

P H Green, J W Riley.   

Abstract

Lipid absorption is a complex process which involves coordinated gastric, intestinal, biliary and pancreatic function. Emulsification of dietary lipid occurs in the stomach and upper intestine where a series of enzymic events also occur. Phospholipids are digested by phospholipases. Colipase anchors lipase to the emulsion surface overcoming the interfering effect of bile salts. The products of lipolysis, monoglycerides and fatty acids, are removed from the emulsion surface by bile salts in the form of mixed micelles which transport lipid digestive products across the unstirred water layer to the epithelial cell. Within the intestinal epithelial cell a series of synthetic events occur resulting in the formation of chylomicrons and very low density lipoprotein (VLDL). Chylomicrons consists of an oily core of triglyceride surrounded by a membrane of phospholipids, free cholesterol and apoproteins which maintain the solubility of the particle in plasma. Chylomicrons from both experimental animals and man have specific apoproteins associated with them. These proteins include apoA-I, the major protein of plasma high density lipoproteins. During chylomicron metabolism, apoA-I and phospholipid from the chylomicron surface contribute to plasma high density lipoproteins. Other chylomicron apoproteins include apoB and apoA-IV, which are synthesized in the intestine, and apoC and apoE which are absorbed onto the chylomicron surface from other lipoproteins. The intestines also synthesizes, very low density sized particles (VLDL) while fasting and during lipid absorption. There is evidence that the intestine also synthesizes high density lipoproteins. The intestine has recently been recognized as a major site of synthesis of plasma lipoproteins and apoproteins, especially apoA-I for plasma high density lipoproteins.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7018485     DOI: 10.1111/j.1445-5994.1981.tb03746.x

Source DB:  PubMed          Journal:  Aust N Z J Med        ISSN: 0004-8291


  7 in total

1.  Gut triglyceride production.

Authors:  Xiaoyue Pan; M Mahmood Hussain
Journal:  Biochim Biophys Acta       Date:  2011-10-02

Review 2.  Role of the gut in modulating lipoprotein metabolism.

Authors:  Alan A Hennessy; R Paul Ross; Gerald F Fitzgerald; Noel Caplice; Catherine Stanton
Journal:  Curr Cardiol Rep       Date:  2014-08       Impact factor: 2.931

3.  Amyloid-beta colocalizes with apolipoprotein B in absorptive cells of the small intestine.

Authors:  Susan Galloway; Ryusuke Takechi; Menuka M S Pallebage-Gamarallage; Satvinder S Dhaliwal; John C L Mamo
Journal:  Lipids Health Dis       Date:  2009-10-22       Impact factor: 3.876

4.  Milk Phospholipids Enhance Lymphatic Absorption of Dietary Sphingomyelin in Lymph-Cannulated Rats.

Authors:  Masashi Morifuji; Seiichiro Higashi; Chisato Oba; Satomi Ichikawa; Keiko Kawahata; Taketo Yamaji; Hiroyuki Itoh; Yuki Manabe; Tatsuya Sugawara
Journal:  Lipids       Date:  2015-08-02       Impact factor: 1.880

5.  A family of fatty acid transporters conserved from mycobacterium to man.

Authors:  D Hirsch; A Stahl; H F Lodish
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

6.  Chronic exposure to rifaximin causes hepatic steatosis in pregnane X receptor-humanized mice.

Authors:  Jie Cheng; Kristopher W Krausz; Naoki Tanaka; Frank J Gonzalez
Journal:  Toxicol Sci       Date:  2012-07-12       Impact factor: 4.849

7.  Ultrastructural demonstration of the absorption and transportation of minute chylomicrons by subepithelial blood capillaries in rat jejunal villi.

Authors:  Ei-Ichirou Takahara; Youhei Mantani; Kankanam Gamage Sanath Udayanga; Wang-Mei Qi; Takashi Tanida; Takashi Takeuchi; Toshifumi Yokoyama; Nobuhiko Hoshi; Hiroshi Kitagawa
Journal:  J Vet Med Sci       Date:  2013-07-26       Impact factor: 1.267

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.